Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (255)

« Back to Publications

CK2-FBXW11 kinase-E3 ubiquitin ligase cascade is a metabolic sensor regulating Tryptophan 2,3-dioxygenase stability

Thielen AS. et al, (2026)

Figure S3 from IFNγ-Induced PD-L1+MHCII+ Macrophages and Tim-3+ Tumor-Reactive CD8+ T Cells Predict a Response to Anti–PD-1 Therapy in Tumor-Bearing Mice

Gabrilo J. et al, (2025)

Figure S11 from IFNγ-Induced PD-L1+MHCII+ Macrophages and Tim-3+ Tumor-Reactive CD8+ T Cells Predict a Response to Anti–PD-1 Therapy in Tumor-Bearing Mice

Gabrilo J. et al, (2025)

Figure S4 from IFNγ-Induced PD-L1+MHCII+ Macrophages and Tim-3+ Tumor-Reactive CD8+ T Cells Predict a Response to Anti–PD-1 Therapy in Tumor-Bearing Mice

Gabrilo J. et al, (2025)

Data from IFNγ-Induced PD-L1+MHCII+ Macrophages and Tim-3+ Tumor-Reactive CD8+ T Cells Predict a Response to Anti–PD-1 Therapy in Tumor-Bearing Mice

Gabrilo J. et al, (2025)

Figure S6 from IFNγ-Induced PD-L1+MHCII+ Macrophages and Tim-3+ Tumor-Reactive CD8+ T Cells Predict a Response to Anti–PD-1 Therapy in Tumor-Bearing Mice

Gabrilo J. et al, (2025)

Figure S2 from IFNγ-Induced PD-L1+MHCII+ Macrophages and Tim-3+ Tumor-Reactive CD8+ T Cells Predict a Response to Anti–PD-1 Therapy in Tumor-Bearing Mice

Gabrilo J. et al, (2025)

Figure S12 from IFNγ-Induced PD-L1+MHCII+ Macrophages and Tim-3+ Tumor-Reactive CD8+ T Cells Predict a Response to Anti–PD-1 Therapy in Tumor-Bearing Mice

Gabrilo J. et al, (2025)

Figure S8 from IFNγ-Induced PD-L1+MHCII+ Macrophages and Tim-3+ Tumor-Reactive CD8+ T Cells Predict a Response to Anti–PD-1 Therapy in Tumor-Bearing Mice

Gabrilo J. et al, (2025)

Figure S1 from IFNγ-Induced PD-L1+MHCII+ Macrophages and Tim-3+ Tumor-Reactive CD8+ T Cells Predict a Response to Anti–PD-1 Therapy in Tumor-Bearing Mice

Gabrilo J. et al, (2025)

IFNγ-Induced PD-L1+MHCII+ Macrophages and Tim-3+ Tumor-Reactive CD8+ T Cells Predict a Response to Anti–PD-1 Therapy in Tumor-Bearing Mice

Gabrilo J. et al, (2025), Cancer Immunology Research, 13, 2004 - 2022

Figure S9 from IFNγ-Induced PD-L1+MHCII+ Macrophages and Tim-3+ Tumor-Reactive CD8+ T Cells Predict a Response to Anti–PD-1 Therapy in Tumor-Bearing Mice

Gabrilo J. et al, (2025)

Figure S10 from IFNγ-Induced PD-L1+MHCII+ Macrophages and Tim-3+ Tumor-Reactive CD8+ T Cells Predict a Response to Anti–PD-1 Therapy in Tumor-Bearing Mice

Gabrilo J. et al, (2025)

Figure S5 from IFNγ-Induced PD-L1+MHCII+ Macrophages and Tim-3+ Tumor-Reactive CD8+ T Cells Predict a Response to Anti–PD-1 Therapy in Tumor-Bearing Mice

Gabrilo J. et al, (2025)

Figure S7 from IFNγ-Induced PD-L1+MHCII+ Macrophages and Tim-3+ Tumor-Reactive CD8+ T Cells Predict a Response to Anti–PD-1 Therapy in Tumor-Bearing Mice

Gabrilo J. et al, (2025)

Load More

1
2
3
4
5
6
7
...
»